Oct 18, 2013

Farmak has developed an anti-inflammatory drug product Betaspan® Depo

Farmak specialists have developed and brought to market a corticosteroid Betaspan® Depo. The new drug is produced in the form of a solution for injection.

Betaspan® Depo is prescribed for the treatment of inflammatory, degenerative, rheumatic diseases, asthma, allergic diseases, dermatitis and autoimmune bowel diseases. The new feature of the drug is its formula consisting of two components – water-soluble and crystalline. The water-soluble component provides a fast initial effect and the crystalline component provides a prolonged effect after a single dose administration up to 28 days.

Betaspan® Depo is available in 5 ampoule packs in the form of a solution for injection.

Back to the News

More news